Adam Porter, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1213 Garfield Ave, Harlan, IA 51537 Phone: 712-755-4341 |
Carrie Dills Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Chatburn Ave, Harlan, IA 51537 Phone: 712-755-2525 Fax: 712-755-3040 |
Lacey Kreisel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1812 Chatburn Plz, Harlan, IA 51537 Phone: 712-755-2101 |
Amy Lynn Keast Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Chatburn Ave, Harlan, IA 51537 Phone: 712-755-2525 |
Greg Leinen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Chatburn Ave, Harlan, IA 51537 Phone: 712-755-2525 Fax: 712-755-3040 |
Jean Feldman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2099 Chatburn Ave, Harlan, IA 51537 Phone: 712-755-1112 Fax: 712-755-1369 |
Kristina Danute Dotzler, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1812 Chatburn Plz, Harlan, IA 51537 Phone: 712-755-2101 Fax: 712-755-5576 |
Richard L Dotzler Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1812 Chatburn Plz, Harlan, IA 51537 Phone: 712-755-2101 Fax: 712-755-5576 |
Mr. Thomas J Fox, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2308 12th St, Harlan, IA 51537 Phone: 712-755-3823 Fax: 712-755-3858 |
News Archive
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today summarized new data highlighting the progress of OncoMed's pipeline of anti-cancer biologics presented this week in an oral presentation and five posters at the Annual Meeting of the American Association of Cancer Research in Washington, DC.
Chocolate, in particular the cocoa-rich dark variety is in the news again because of it's apparent health benefits.
The global supply of oral cholera vaccines is set to double after WHO approved a third producer, helping to address global shortages and expand access in more countries.
Researchers with Deakin's Centre for Physical Activity and Nutrition Research surveyed more than 1200 families to find out if parents had concerns about their children's weight and if they took any preventative action to avoid obesity in their children.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
› Verified 8 days ago